The Optical Biopsy Blog - Mauna Kea Technologies' Official Corporate Blog

Modern Healthcare Heroes: Inspiring Innovation in the Medical World

Posted by Sacha Loiseau

March 30, 2015 at 12:53 PM

Last week, I had the honor of giving a guest lecture as part of Professor Gregory Katz’s “Chair of Therapeutic Innovation” initiative at the prestigious French business school, ESSEC. The course, as he describes it, aims to “ignite fires” and train “the upcoming generation of decision-makers in innovation management and stimulate their sense of ethical leadership.” 

It is always a pleasure sharing the story of Mauna Kea Technologies’ creation with enthusiastic and engaging audiences like the one I met at ESSEC. 

 
Sacha Loiseau speaking at ESSEC. Photo Credit: @Louisemartinlm
Read More

Topics: Mauna Kea Technologies, Optical Biopsy, Innovation, Pancreatic Cysts

Positive results from endomicroscopy pivotal trial on biliary cancer

Posted by Sacha Loiseau

January 29, 2015 at 12:09 PM

Dr. Adam Slivka discusses the results of the study.

Mauna Kea Technologies announced positive results from FOCUS, a pivotal clinical trial on the use of probe-based Confocal Laser Endomicroscopy (pCLE) in biliary cancer detection. This trial enrolled 112 patients in 6 centers, 4 in the U.S., one in France, and one in Italy.

The publication appears in this month's issue of GIE as the highlighted paper with an accompanying editorial "Distinguishing malignant from benign biliary strictures: can confocal laser endomicroscopy close the gap?"

Thanks to the addition of pCLE during standard interventional procedures, the sensitivity of cancer detection jumps from 56% for ERCP + biopsies to 89% for ERCP + pCLE.

Read More

Topics: Optical Biopsy, Clinical Updates

Dr. Wellikoff talks about Cellvizio and Lung Cancer Awareness Month

Posted by Sacha Loiseau

November 25, 2014 at 12:48 PM

In August 2012, Dr. Adam Wellikoff and other physicians at the Louisiana State University Health Sciences Center Shreveport began using Cellvizio to spot potential lung cancers. It was one of the first hospitals in southeastern United States to use our imaging technology to see into a patient’s lung at the cellular level by threading Cellvizio through a bronchoscope.     

As we recognize Lung Cancer Awareness Month this November, Dr. Wellikoff took some time with us to reflect on how he is using Cellvizio Optical Endomicroscopy to see changes to the lung and talked about future applications for the technology. 

“We started using Cellvizio to improve our diagnostic yield when performing biopsies,” said Dr. Wellikoff. “Also, working at an academic institution the research capacity was attractive.”

Read More

Topics: Optical Biopsy

Building Consensus as the International Community of Cellvizio Users Expands

Posted by Sacha Loiseau, Ph.D., President and CEO

June 25, 2014 at 10:44 AM

In any discipline, and particularly in the field of medicine, change takes time. Advanced technology that disrupts the traditional way of doing things requires early adopters who see value and are eager to share the potential with their peers. As technology becomes more accessible, a large community is formed that carries significant weight in advocacy and in practice. That is the case for Cellvizio and the future of Optical Biopsy.

Read More

Topics: Mauna Kea Technologies, Company news, Optical Biopsy

Commitment to Communication: Introducing the Mauna Kea Corporate Blog

Posted by Sacha Loiseau, Ph.D., President and CEO

April 29, 2014 at 11:47 AM

In a world where communication about health, technology, and business is taking place on platforms for real-time conversations with many different audiences, at Mauna Kea Technologies we have decided it’s time to take an important new step in our ongoing commitment to keeping you informed about our progress in delivering the benefits of Cellvizio to patients and clinicians around the world. This new blog is an opportunity for us to provide perspectives on our business strategy and progress.

In the coming months we’ll provide updates on clinical research and publications that support our mission to position optical biopsy as the standard of care in multiple therapeutic areas and indications in the years ahead. We’ll share many of the compelling case studies that show how cutting-edge imaging technology is bringing the smallest microscope in the world to the patient, with critical benefits including real-time evaluation of tissue with immediate diagnostic results to support faster and more effective intervention. We’ll also post content developed by clinicians from around the world who share their perspectives with us, and we’ll give you additional insights about our news to show how important developments fuel our growth.

Read More

Topics: Mauna Kea Technologies, Company news, Optical Biopsy

     

About this blog

The latest news and information about Mauna Kea Technologies and Cellvizio Optical Biopsy, the Fastest Way to See Cancer. 

Subscribe to Email Updates